| Trial-Results center | |||
| Clinical trial results database |
 Feedback
 Home
|
This trial is included in the following systematic reviews and meta-analyses:
percutaneous coronary intervention
-
antithrombotics
-
all type of patients
Related trials
ATOLL, 2010 - enoxaparin vs standard heparin
TRA-PCI, 2009 - SCH 530348 vs placebo
NAPLES (Tavano), 2009 - bivalirudin vs actionated heparin plus tirofiban
CHAMPION-PCI, 2009 - cangrelor up front vs clopidogrel up front
CHAMPION-PLATFORM, 2009 - cangrelor up front vs delayed clopidogrel
ISAR-REACT 3, 2008 - bivalirudin vs UFH
HORIZONS-AMI (Stone), 2008 - bivalirudin vs Heparin plus GP IIb/IIIa inhibitor
STEEPLE, 2006 - enoxaparin vs UFH
ACUITY (Stone) (bivalirudin alone), 2006 - bivalirudin vs heparin + anti Gp2b3a
JUMBO-TIMI 26, 2005 - prasugrel vs clopidogrel
REPLACE-1, 2004 - bivalirudin vs UFH
Natarajan (without antiGp2b3a), 2003 - Dalteparin vs UFH
REPLACE-2, 2003 - bivalirudin vs hepatin + anti Gp2b3a
CRUISE, 2003 - Enoxaparin vs UFH
Natarajan (+ antiGp2b3a), 2003 - Dalteparin vs UFH + anti Gp2b3a
Petronio, 2002 - Abciximab vs placebo
Tamburino, 2002 - Abciximab vs placebo
Kleiman, 2002 - bivalirudin + eptifibatide vs heparin + eptifibatide
CADILLAC, 2002 - Abciximab vs placebo
Dubek b (+abciximal), 2001 - Enoxaparin+abciximab vs UFH
ADMIRAL, 2001 - Abciximab vs placebo
Galeote, 2001 - Enoxaparin vs UFH
Drozd, 2001 - Enoxaparin vs UFH
See also:
BRAVE-4 study, |
|
| [NCT00976092] Ongoing trial | |
Treatments
| Studied treatment |
Prasugrel + Bivalirudin
60 mg prasugrel as loading dose prior to PPCI, Bivalirudin IV bolus 0.75 mg/kg of body weight followed by an infusion of 1.75 mg/kg/hour during the PPCI |
| Control treatment |
Clopidogrel + Heparin
600 mg clopidogrel as loading dose before PPCI,Heparin i.v. bolus of 100 IE/body weight during PPCI |
Patients
| Patients | STEMI patients undergoing PPCI |
Method and design
| Randomized effectives | NA / NA (studied vs. control) |
Results
No results available for this trial - ongoing study
Reference(s)
| Trials register # | NCT00976092 |
(c) 2004-2010 TrialResults-center - All Rights Reserved
Tweet this
notify a friend